ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print February 12, 2009
Eur Respir J 2009, doi:10.1183/09031936.00145208
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
33/4/771    most recent
09031936.00145208v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mahler, D.A.
Right arrow Articles by Baird, J.C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mahler, D.A.
Right arrow Articles by Baird, J.C.


ORIGINAL ARTICLE

Endogenous opioids modify dyspnoea during treadmill exercise in patients with COPD

D.A. Mahler 1*, J.A. Murray 2, L.A. Waterman 3, J. Ward 3, W.J. Kraemer 4, X. Zhang 1, J.C. Baird 5

1 Section of Pulmonary & Critical Care Medicine, Dartmouth Medical School, Hanover, NH, USA
2 Unity Health System, Rochester, NY, USA
3 Pulmonary Function & Cardiopulmonary Exercise Laboratories, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
4 University of Connecticut, Storrs, CT, USA
5 Section of Pulmonary & Critical Care Medicine, Dartmouth Medical School, Hanover, NH, USA; and Psychological Applications, South Pomfret, VT, USA

* To whom correspondence should be addressed. E-mail: Donald.a.mahler{at}hitchcock.org.


   Abstract

Exogenous opioid drugs, such as morphine, relieve breathlessness. Our hypothesis is that endogenous opioids, released during the stress of exercise, modify dyspnoea in patients with chronic obstructive pulmonary disease.

After familiarization, patients performed an incremental treadmill exercise test followed by constant work on the treadmill for 10 minutes. At subsequent visits (2 to 3 days apart): patients received 2 puffs of albuterol; had a catheter placed in an arm vein for removal of blood to measure beta-endorphin immunoreactivity; received normal saline or 10 mg of naloxone intravenously in randomized order; and then performed high intensity constant work rate exercise on treadmill.

Age of the seventeen patients (8 females/9 males) was 63±7 years, and post-bronchodilator FEV1 was 50±17% predicted. In both conditions beta-endorphin levels increased three-fold from rest to end-exercise. The regression slope of breathlessness as a function of oxygen consumption (primary outcome), mean ratings of breathlessness throughout exercise, and peak ratings of breathlessness were significantly higher with naloxone than normal saline. There were no differences in physiological responses throughout exercise between conditions.

We conclude that endogenous opioids modify dyspnoea during treadmill exercise in patients with chronic obstructive pulmonary disease by apparent alteration of central perception.

Keywords:  Beta-endorphin immunoreactivity, chronic obstructive pulmonary disease, continuous ratings of breathlessness, naloxone, treadmill exercise







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2009 by the European Respiratory Society.